Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."


TSX:TST - Post by User

Comment by scroll4factson Aug 16, 2016 10:43am
248 Views
Post# 25145790

RE:RE:New and improved

RE:RE:New and improvedI am one of those who can't believe that MCNA has been put on a shelf with almost no value
attached to it.  So much time, efforts, dilution, and shareholder's money have been put into it.  At one point ENDO and Ipsen were among those who also saw its tremendous potential.  It could have easily been worth over $1 billion if the panel had voted yes and the FDA given their thumbs up.  A 18-6 results seems decisive, but really most urologists on the comity were in favor of the approval and i think that most of the "no" votes could have been turned around if the trail design had been somewhat more robust   So MCNA is worth nothing?  Really?  I don't get it. The unmet medical needs are huge, the safety profile is great, and the potential antitumor activity looks quite promising in my opinion.  I don't see why a major biotech or pharma wouldn't pay $100M+ for this platform and give it another try.

https://www.onclive.com/web-exclusives/fda-panel-rejects-immunotherapy-mcna-in-bladder-cancer
<< Previous
Bullboard Posts
Next >>